Literature DB >> 10395432

Effective management of spinal pain in one hundred seventy-seven patients evaluated for manipulation under anesthesia.

D T West1, R S Mathews, M R Miller, G M Kent.   

Abstract

OBJECTIVE: To demonstrate that manipulation under anesthesia (MUA), a conservative treatment modality, is both safe and efficacious in the treatment of both acute and chronic spinal pain disorders in appropriately selected patients. MUA can be safely used to treat pain arising from the cranial, cervical, thoracic, and lumbar spine, as well as the sacroiliac and pelvic region.
SETTING: An ambulatory surgical center.
SUBJECTS: The treatment group consisted of 177 patients between ages 17 and 65 years. Evaluation followed a treatment algorithm created by the authors as a multidisciplinary approach to patient selection, evaluation, treatment, and timing of specialized referral, in consideration of previously published algorithms. Prior forms of treatment, both conservative and surgical in nature, had failed in these patients. INTERVENTION: Patients underwent three sequential manipulations under intravenous sedation, followed by 4 to 6 weeks of skilled spinal manipulation and therapeutic modalities. OUTCOME MEASURES: Data regarding changes in Visual Analog Scale (VAS), range of motion, medication needs, and return to work status were used to document progress. All patients had follow-up for 6 months.
RESULTS: On average, VAS ratings improved by 62.2% in those patients with cervical pain problems. On average, VAS ratings improved by 60.1% in those patients with lumbar pain problems. There was a near-complete reversal in patients out of work before MUA (68.6%) and those returning to unrestricted activities at 6 months after MUA (64.1%). There was a 58.4% reduction in the percentage of patients requiring prescription pain medication from the pre-MUA period to 6 months after MUA. Additionally, 24.0% of the treatment group required no medication at 6 months after MUA.
CONCLUSION: A multidisciplinary approach to evaluation and treatment, including MUA, offers patient benefits above and beyond what can be obtained through the individual providers working alone.

Entities:  

Mesh:

Year:  1999        PMID: 10395432     DOI: 10.1016/s0161-4754(99)70062-x

Source DB:  PubMed          Journal:  J Manipulative Physiol Ther        ISSN: 0161-4754            Impact factor:   1.437


  8 in total

1.  Management of a 59-year-old female patient with adult degenerative scoliosis using manipulation under anesthesia.

Authors:  Mark W Morningstar; Megan N Strauchman
Journal:  J Chiropr Med       Date:  2010-06

2.  Manipulation under anesthesia for lumbopelvic pain: a retrospective review of 18 cases.

Authors:  Douglas J Taber; Gary D James; Alain Jacon
Journal:  J Chiropr Med       Date:  2014-03

3.  Neck and Back Pain in the Elderly.

Authors:  Steven N. Kalkanis; Lawrence Borges
Journal:  Curr Treat Options Neurol       Date:  2001-05       Impact factor: 3.598

4.  A functional pre-manipulative spinal orthopedic assessment maneuver.

Authors:  David E Stude
Journal:  J Chiropr Med       Date:  2005

5.  Chiropractic clinical practice guideline: evidence-based treatment of adult neck pain not due to whiplash.

Authors:  Elizabeth Anderson-Peacock; Jean-Sébastien Blouin; Roland Bryans; Normand Danis; Andrea Furlan; Henri Marcoux; Brock Potter; Rick Ruegg; Janice Gross Stein; Eleanor White
Journal:  J Can Chiropr Assoc       Date:  2005-09

6.  Spinal manipulation under anesthesia: a narrative review of the literature and commentary.

Authors:  Dennis Digiorgi
Journal:  Chiropr Man Therap       Date:  2013-05-14

7.  Scoliosis treatment using spinal manipulation and the Pettibon Weighting System: a summary of 3 atypical presentations.

Authors:  Mark W Morningstar; Timothy Joy
Journal:  Chiropr Osteopat       Date:  2006-01-12

8.  Scoliosis treatment using a combination of manipulative and rehabilitative therapy: a retrospective case series.

Authors:  Mark W Morningstar; Dennis Woggon; Gary Lawrence
Journal:  BMC Musculoskelet Disord       Date:  2004-09-14       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.